BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28194632)

  • 21. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
    van Laarhoven HW; de Geus-Oei LF; Wiering B; Lok J; Rijpkema M; Kaanders JH; Krabbe PF; Ruers T; Punt CJ; van der Kogel AJ; Oyen WJ; Heerschap A
    Radiology; 2005 Oct; 237(1):181-8. PubMed ID: 16183932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
    Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
    Haldorsen IS; Popa M; Fonnes T; Brekke N; Kopperud R; Visser NC; Rygh CB; Pavlin T; Salvesen HB; McCormack E; Krakstad C
    PLoS One; 2015; 10(8):e0135220. PubMed ID: 26252891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
    Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
    Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of R-2-[
    Zhang Z; Liu S; Ma H; Nie D; Wen F; Zhao J; Sun A; Yuan G; Su S; Xiang X; Hu P; Tang G
    Mol Imaging Biol; 2019 Dec; 21(6):1127-1137. PubMed ID: 30847820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.
    Yoshikawa H; Randall EK; Kraft SL; Larue SM
    Vet Radiol Ultrasound; 2013; 54(3):307-13. PubMed ID: 23441633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR.
    Catalano OA; Coutinho AM; Sahani DV; Vangel MG; Gee MS; Hahn PF; Witzel T; Soricelli A; Salvatore M; Catana C; Mahmood U; Rosen BR; Gervais D
    Abdom Radiol (NY); 2017 Apr; 42(4):1141-1151. PubMed ID: 27891551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
    Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A
    Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
    Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
    Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography.
    Francis DL; Freeman A; Visvikis D; Costa DC; Luthra SK; Novelli M; Taylor I; Ell PJ
    Gut; 2003 Nov; 52(11):1602-6. PubMed ID: 14570730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.
    Jiang H; Guo W; Huang K; Jiang H; Zhang R; Hu H; Lin X; Wang S
    Abdom Radiol (NY); 2021 Jul; 46(7):3227-3237. PubMed ID: 33712897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 38. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
    Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
    Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.